We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Conflicted Panel Supports UCB Arthritis sBLA, But Not AbbVie’s
Conflicted Panel Supports UCB Arthritis sBLA, But Not AbbVie’s
July 26, 2013
An FDA advisory panel tasked with clearing up clinical trial uncertainty surrounding a pair of sBLAs for two TNF-blockers may have sowed further confusion July 23.